Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1977 Jun;40(6):570–574. doi: 10.1136/jnnp.40.6.570

Effect of sodium valproate on plasma protein binding of diphenylhydantoin.

P N Patsalos, P T Lascelles
PMCID: PMC492763  PMID: 20483

Abstract

In vivo and in vitro experimental data are presented in support of the hypothesis that sodium valproate displaces diphenylhydantoin (DPH) from plasma protein binding sites. This interaction could have important practical implications in the management of patients on combined therapy with these two drugs. Acute neurological features of DPH intoxication may be precipitated as a result of an increased free (pharmacologically active) fraction, which would not be detected by routine plasma DPH estimations since these reflects largely the bound fraction.

Full text

PDF
570

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen R. F. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem. 1967 Jan 25;242(2):173–181. [PubMed] [Google Scholar]
  2. Hansen J. M., Kristensen M., Skovsted L. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism. Epilepsia. 1968 Mar;9(1):17–22. doi: 10.1111/j.1528-1157.1968.tb04954.x. [DOI] [PubMed] [Google Scholar]
  3. Hooper W. D., Sutherland J. M., Bochner F., Tyrer J. H., Eadie M. J. The effect of certain drugs on the plasma protein binding of phenytoin. Aust N Z J Med. 1973 Aug;3(4):377–381. doi: 10.1111/j.1445-5994.1973.tb03109.x. [DOI] [PubMed] [Google Scholar]
  4. Jeavons P. M., Clark J. E. Sodium valproate in treatment of epilepsy. Br Med J. 1974 Jun 15;2(5919):584–586. doi: 10.1136/bmj.2.5919.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lunde P. K., Rane A., Yaffe S. J., Lund L., Sjöqvist F. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution. Clin Pharmacol Ther. 1970 Nov-Dec;11(6):846–855. doi: 10.1002/cpt1970116846. [DOI] [PubMed] [Google Scholar]
  6. Meinardi H. Clinical trials of anti-epileptic drugs. Psychiatr Neurol Neurochir. 1971 Mar-Apr;74(2):141–151. [PubMed] [Google Scholar]
  7. Toseland P. A., Grove J., Berry D. J. An isothermal GLC determination of the plasma levels of carbamazepine, diphenylhydantoin, phenobarbitone and primidone. Clin Chim Acta. 1972 May;38(2):321–328. doi: 10.1016/0009-8981(72)90122-2. [DOI] [PubMed] [Google Scholar]
  8. Tsutsumi E., Inaba T., Mahon W. A. The displacing effect of a fatty acid on the binding of diazepam to human serum albumin. Biochem Pharmacol. 1975 Jul 15;24(13-14):1361–1362. doi: 10.1016/0006-2952(75)90355-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES